Please wait while the formulary information is being retrieved.
REFENESEN DM (GUAIFENESIN/DEXTROMETHORPHAN HBR)
- Cough
- Zyncof Tablet
- Tussin Dm Tablet
- Refenesen Dm Tablet
- Mucus Relief Dm Tablet
- Mucus Relief Dm Cough Tablet
- Mucosa Dm Tablet
- G-fenesin Dm Tablet
- Fenesin Dm Ir Tablet
- Dextromethorphan-guaifenesin Tablet
- Chest Congestion-cough Relief Tablet
- Chest Congestion Relief Dm Tablet
- Chest Congestion Relief + Dm Tablet
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
15 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
15 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
20 mg-400 mg tablet
- Dosage information is not available
- Azilect
- Eldepryl
- isocarboxazid
- linezolid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- rasagiline
- selegiline HCl
- tranylcypromine
- Zelapar
- Zyvox
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Systemic mastocytosis
Severe
Moderate
- No disease contraindications
REFENESEN DM (GUAIFENESIN/DEXTROMETHORPHAN HBR)
- Cough
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Vomiting
Less Severe
- Abdominal pain with cramps
- Dizziness
- Drowsy
- Gastrointestinal irritation
- Nausea
- Vomiting
Contraindicated
Dextromethorphan (OTC)
Do not use in pediatrics <6 years of age unless clinician consultation.
- 1 Day – 6 Years
- 1 Do not use in pediatrics <6 years of age unless clinician consultation.
Severe Precaution
None
Management or Monitoring Precaution
Guaifenesin (solid dose form)
Consult clinician for use in pediatrics age < 12 years.
- 1 Day – 12 Years
- Consult clinician for use in pediatrics age < 12 years.
Dextromethorphan
- Severity Level:
C
- Additional Notes:
Guaifenesin
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Dextromethorphan
Insufficient data available; molecular wt low enough for possible excretion
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available; molecular wt low enough for possible excretion |
Guaifenesin
Insufficient data available; molecular wt low enough for possible excretion
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Cough | |
| R05 | Cough |
| 0-9 | A-Z |
|---|---|
| R05 | Cough |
Formulary Reference Tool